380 results on '"Wieske, Luuk"'
Search Results
2. Immune responses to SARS-CoV-2 in sub-Saharan Africa and western Europe: a retrospective, population-based, cross-sectional study
3. Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy
4. mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses
5. Artificial intelligence-based classification of motor unit action potentials in real-world needle EMG recordings
6. Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity
7. Distinct dynamics of antigen-specific induction and differentiation of different CD11c+Tbet+ B-cell subsets
8. Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
9. Comprehensive overview of autoantibody isotype and subclass distribution
10. Serum neurofilament light chain, contactin-1 and complement activation in anti-MAG IgM paraprotein-related peripheral neuropathy
11. Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies
12. Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study
13. Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies
14. Fluid Biomarkers for Monitoring Structural Changes in Polyneuropathies: Their Use in Clinical Practice and Trials
15. Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases
16. Consumptive coagulopathy is associated with a disturbed host response in patients with sepsis
17. Patient‐reported daily functioning after SARS‐CoV‐2 vaccinations in autoimmune neuromuscular diseases.
18. Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod
19. Inflammatory Neuropathy Consortium base (INCbase):a protocol of a global prospective observational cohort study for the development of a prediction model for treatment response in chronic inflammatory demyelinating polyneuropathy
20. Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy
21. T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination
22. Challenges in the Early Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Adults: Current Perspectives
23. T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination
24. mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses
25. T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination
26. Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection
27. Challenges in the Early Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Adults: Current Perspectives
28. Suppressed IgG4 class switching in dupilumab‐ and TNF inhibitor‐treated patients after mRNA vaccination.
29. Proximity extension assay-based discovery of biomarkers for disease activity in chronic inflammatory demyelinating polyneuropathy.
30. Intravenous immunoglobulins in patients with clinically suspected chronic immune-mediated neuropathy
31. Serum Contactin-1 in CIDP: A Cross-Sectional Study
32. Longitudinal increase of humoral responses after four SARS-CoV-2 vaccinations and infection in MS patients on fingolimod
33. Proximity extension assay-based discovery of biomarkers for disease activity in chronic inflammatory demyelinating polyneuropathy
34. Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort
35. Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after repeated SARS-CoV-2 mRNA vaccination
36. Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study
37. Serum B-cell activating factor is not a potential biomarker for disease activity in chronic inflammatory demyelinating polyneuropathy
38. Reply: Peripherin is a biomarker of axonal damage in Guillain Barré syndrome: a pathophysiological annotation
39. Peripherin is a biomarker of axonal damage in peripheral nervous system disease
40. Correction to: Fluid Biomarkers for Monitoring Structural Changes in Polyneuropathies: Their Use in Clinical Practice and Trials
41. Age-dependent differences in pulmonary host responses in ARDS: a prospective observational cohort study
42. B-cell targeting with anti-CD38 daratumumab:implications for differentiation and memory responses
43. Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
44. SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy
45. Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases:long-term humoral immune responses and effects on disease activity
46. Gut barrier dysfunction and the risk of ICU-acquired bacteremia- a case–control study.
47. Longitudinal increase of humoral responses after four SARS-CoV-2 vaccinations and infection in MS patients on fingolimod.
48. Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort.
49. Long-term tactile hypersensitivity after nerve crush injury in mice is characterized by the persistence of intact sensory axons
50. Diagnostic accuracy of quantitative neuromuscular ultrasound for the diagnosis of intensive care unit-acquired weakness: a cross-sectional observational study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.